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Abstract
The goal of this experiment was to determine if trends exist in the fragmentation pat-
terns of heptapeptides containing lysine and its non-protein amino acid analogs (or-
nithine, daba, dapa). Previous research in the laboratory of Dr. J. C. Poutsma on
pentapeptides suggested that the length of the side chain on the lysine analog played a
role in peptide fragmentation pathways. This study, however, found no such connection
between length of side chain and fragmentation patterns suggesting that as a peptide
lengthens the flexibility of the peptide bonds outweigh the side chain length factor in
determining fragmentation patterns.
Chapter 1
Introduction
1.1 Proteins
All living things are made of proteins as well as other natural components. Proteins
are especially interesting because they are encoded in deoxyribonucleic acid (DNA)
which is then transcribed into messenger ribonucleic acid (mRNA) and finally translated
into a polypeptide that can become a protein.1 This flow of information from DNA to
protein was named The Central Dogma of Molecular Biology by Francis Crick in a
paper of the same name published in 1970.2 The study of proteins (proteomics) has
expanded greatly since the mechanism of cellular protein synthesis was discovered. The
development of this field has been heavily reliant on protein sequencing using mass
spectrometry techniques.
1.1.1 Protein Structure
Proteins in their most basic form are polymers of amino acids. The one-dimensional
amino acid sequence of a protein is the primary structure of the protein. This is simply
the long line of amino acids linked by peptide bonds through dehydration reactions
mediated and catalyzed by ribosomes. Amino acids consist of a central carbon atom
joined to an amino group, a carboxylic acid group, a hydrogen atom, and a distinguishing
R group.3 Figure 1.1 is an example of an amino acid that is doubly protonated (both on
1
Figure 1.1 – An Amino Acid
the amine and on the carboxylic acid). Segments of mRNA, each three nucleotides long,
code for a single amino acid. Theoretically, with four nucleotides and three locations,
there could be sixty four different amino acids encoded, but because of multiplicity in
the code, this is not the case.4 For many years it was thought that there were only
twenty genetically encoded amino acids, however recent developments have led to the
discovery of the twenty first and twenty second genetically encoded amino acids.5,6 At
this point, however, it seems unlikely that additional widely-spread genetically encoded
amino acids will be discovered.7
As ribosomes link amino acids within the cells, the primary structure quickly begins
to interact with itself forming a number of common structural motifs which are associ-
ated with a protein’s secondary structure. The α-helix and β-pleated sheet are the most
widely seen structural elements. The α-helix is a right-handed helical motif, stabilized
by intrachain hydrogen bonding between the carbonyl group of one residue with the
NH of a residue four amino acids away.3 The β-pleated sheet is also stabilized through
hydrogen bonds, though due to its more extended structure, the hydrogen bonds are
between polypeptide strands.
Proteins can fold further into a tertiary structure and even associate with other
protein units to create a quaternary structure. The tertiary structure of a protein
(in an aqueous environment) is driven by the effects of the hydrophobic, non-polar,
residues (leucine, valine, methionine, and phenylalanine) burying themselves in the core
of the protein, away from water. The tertiary structure of a protein is often functional.
Myoglobin, a 153 amino acid globular protein, exhibits a functional three dimensional
tertiary structure containing a very non-polar core.3
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The highest level of protein structure is the quaternary structure that occurs in
some proteins by multiple subunits coming together to make a functional oligomer.
Hemoglobin is an example of a quaternary protein which has four total subunits, two
of the α type and two of the β type. The use of multiple subunits allows cooperative
binding of the protein to oxygen. Small changes in protein conformation through the
binding of oxygen to one subunit allow the other subunits to bind oxygen more easily.3
1.1.2 Protein Sequencing
Edman Degradation
Before the widespread use of mass spectrometry in protein sequencing, researchers
used other analytical techniques. One of the first techniques was Edman degradation
where short, purified proteins were chemically degraded one amino acid at a time from
the N terminus to the C terminus. Ultraviolet spectroscopy was used to identify each
amino acid.8 This technique was time consuming and only worked well on short, and
highly purified proteins. Even more problematic is that Edman Degradation will not
work on peptides blocked at their N-termini. This type of modication is common in
biosynthesis (acetylation, formylation, pyroglutamyl formation)9 and can cause prob-
lems when sequencing through the Edman degradation/UV spectroscopy method.10 A
new technique was needed to rapidly identify and sequence proteins.
Use of Mass Spectrometry in Protein Sequencing
This new technique would prove to be the use of mass spectrometry as the sequencing
method of choice, replacing Edman degradation by the mid 1990s. Mass spectrometry
techniques allow for the identification of proteins within seconds instead of the hours or
days that Edman degradation requires. Also, by using mass spectrometry, it is possible
to identify proteins that are not purified.11 As seen in Figure 1.2, the bottom up, or
shotgun approach,10 is a common and straightforward method to identify a protein.
Notably, the protein itself is not being submitted to mass spectrometry but is first
cut into many fragments by a protease, most often trypsin, which cleaves proteins on
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the C-terminal side of the amino acids arginine and lysine. Usually it is best to have
fragments of twenty amino acids or less, though advances in the field are allowing the
use of an entire protein in a mass spectrometer to reveal some sequence information.11
Additional proteases that cleave at different sites, like chymotrysin are used to order
the peptide fragments due to their resultant overlapping peptides.3
Figure 1.2 – Protein Sequencing via Mass Spectrometry11
Once the proteases cut the protein into short polypeptides, they are injected into a
high performance liquid chromatography (HPLC) column that separates the polypep-
tides by their hydrophobicity. The HPLC then feeds the separated polypeptides directly
into a mass spectrometer for identification.
The two major ways to introduce proteins into mass spectrometers are electrospray
ionization (ESI) and matrix assisted laser desorption/ionization (MALDI). Both tech-
niques are soft ionization methods that lead to less fragmenting of fragile molecules
(like proteins) compared to a more conventional mass spectrometer ionization source
such as electron ionization. Electron ionization works by accelerating electrons through
differentially charged plates until they collide with the molecules of interest and cre-
ate ions. Instead of colliding electrons with molecules, electrospray ionization creates
charged particles by passing the already protonated sample fragments through a charged
nebulizer that creates a mist of charged fragments. The liquid in the mist evaporates,
leaving the molecules of interest in the gas phase. ESI often results in a variety of charge
states on the resultant ions. Because of this, a new variant, electrosonic spray ionization
(ESSI), has been developed that creates ions with fewer charge states.12 MALDI sources
use a pulsed laser to create molecules in the gas phase from a light-absorbing matrix
(typically made with a compound containing conjugated aromatic rings12) mixed with
the sample. The sample and the matrix are vaporized. In the process of vaporization
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charged particles are created. MALDI sources are usually coupled with time of flight
(TOF) mass analyzers and work well with proteins, regardless of size.13 As the matrix
expands into the gas phase, it carries the charged protein fragments along.14
Tandem mass spectroscopy or MS/MS is used for most analysis of these charged
particles. In this technique, two (or more in MSn) mass spectrometers are connected
in series. The first mass spectrometer selects a precursor ion and focuses it into an
intermediate region containing an inert gas. Here the ion collides with the inert gas
and creates unstable excited-state ions that decompose into the final product ions that
are measured in the second mass spectrometer. This method is called collision-induced
dissociation (CID).14
There are a number of different ways for mass spectrometers to determine the mass
to charge (m/z) ratio of the ionized peptide sample. Typically, one of four types of
mass analyzers is used in mass spectrometers when working with biomolecules. Fourier
transform ion cyclotron resonance (FTICR) is the most sensitive, using magnetic fields
to trap the ions and cyclotron resonance to excite the ions. FTICR can typically resolve
a m/z ratio of 1000.000 from a m/z of 1000.001. Another method, time of flight (TOF)
analysis, uses a voltage gradient to accelerate the ions into a region devoid of fields. The
instrument then measures the time for the ions to cross through this region that varies as
the square root of the charge to mass ratio. A TOF analyzer is much less sensitive than
FTICR, only able to resolve a m/z ratio of 1000.0 from 1000.1. The most rudimentary
sensor used is a quadrupole mass analyzer. These use radio frequency electromagnetic
waves to only allow a small range of m/z particles to the sensor. Improving on this
method is the quadrupole ion trap which focus the ions into a trap which increases
resolution over the plain quadrupole mass analyzer as it uses methods of tandem mass
spectroscopy and is able to quickly switch between MS and MS/MS.12
Peptides fragment in mass spectrometers in two different ways. If the bonds along
the peptide backbone are broken in such a way that the charge remains on the side of
the N-terminus, the ion is an a-, b-, or c-type depending on the bond that is broken.
Likewise, if the charge ends up on the fragment containing the C-terminus, the ion is
5
Figure 1.3 – Peptide Fragmentation Nomenclature15
an x, y, or z (Figure 1.3). The distinction between types of fragments is very important
in understanding the directive effects that certain amino acids have on the fragmenta-
tion of peptides. While an incredible amount of empirical evidence has been collected
on peptide fragmentation patterns, much less information has been learned about the
mechanism for the peptide fragmentation process.14
1.2 Directed Peptide Fragmentation
1.2.1 Mobile Proton Model
The way that protonated peptides fragment within a mass spectrometer has been the
focus of many studies. The current prevailing theory is called the mobile proton model.
This model proposes that fragmentation of protonated peptides requires the presence
of the proton at the site of fragmentation. The more basic an amino acid sidechain, the
more tightly it sequesters a proton, meaning that it will require more energy for the
proton to localize on the peptide backbone and initiate cleavage.16
These are charge directed reactions because the model proposes that the proton
needs to be present at the site of cleavage. Protonated peptides in low-energy collision
conditions tend to fragment via these charge directed reactions.17 Since peptides have so
many functional groups, special interest has been focused on the location of the proton
leading to cleavage. Several groups have shown that protonation on the amide nitrogen
weakens the amide bond while protonation on the amide oxygen strengthens the amide
6
Figure 1.4 – Scheme 1 for Peptide Fragmentation16
bond.18,19
Interestingly, while protonation on the amide nitrogen is favorable for fragmentation,
it is not favorable from a thermodynamics point of view.17 This supposed problem is
explained by the fact that when excited, the proton will migrate along the peptide’s var-
ious protonation sites until the peptide fragments. Several schemes have been proposed
for the mechanism of this fragmentation.
Scheme 1
Scheme 1 for peptide fragmentation (Figure 1.4) consists of protonation at a carbonyl
oxygen of an amide bond. Another carbonyl oxygen in the vicinity acts as a nucleophile
and attacks the carbon of the protonated carbonyl. The end result is an oxazolone b
ion, or through a more complicated ion-molecule complex an y ion can form.16
Scheme 2
Scheme 2 for peptide fragmentation (Figure 1.5) is a special case offering insight into
cleavage at acidic residues (aspartic acid and glutamic acid). Researchers have proposed
that in the case of an acidic residue, the side chain tightly binds the proton which allows
the hydrogen of the side chain to be the reactive proton.16
7
Figure 1.5 – Scheme 2 for Peptide Fragmentation (acidic residues)16
Scheme 3
Scheme 3 is most useful for examining the role that histidine plays in peptide fragmenta-
tions as it has been shown to enhance cleavage near itself. This fragmentation pathway
is interesting because it involves an intermediate that can continue to doubly charged
b2+ ions or a singly charged b+ and y+. The mechanism is shown in Figure 1.6.16
1.2.2 Proline Effect
Most amino acids (with the exceptions of those discussed previously) lead to ran-
dom fragmentation patterns that allow for complete sequence coverage of the peptide
under study. However, some amino acids such as proline and lysine cause selective
fragmentation, which can lead to a loss of sequence coverage. Proline is especially inter-
esting because it is the only amino acid found in mammal proteins that has a secondary
amine14 perhaps playing a part in its directed peptide fragmentation. These fragmen-
tation patterns are important for understanding the spectra produced by peptides and
ultimately in sequencing proteins. By understanding how specific amino acid residues
8
Figure 1.6 – Scheme 3 for Peptide Fragmentation (Histidine residues)16
9
promote certain types of fragmentation, sequencing algorithms that rely on predicted
mass spectra of peptides can be improved.
Wysoki’s group at the University of Arizona did a statistical analysis of peptide
fragmentation by examining a database of hundreds of peptide spectra taken through
MS/MS. A-, b-, and y- type fragmentation on both sides of proline were examined
(Xxx-Pro and Pro-Xxx) as these are the ions most used in sequencing algorithms such
as Sequest. It was found that Pro-Xxx cleavages do not occur often. The most abundant
fragment of this type was when Xxx was proline and even then, the overall intensity of
this fragment was only 4.5%. However, in Xxx-Pro fragmentation (N-terminal) 36.5%
of the a-, b-, and y-type fragmentation intensity was focused here. When Xxx was Val,
His, Asp, Ile, or Leu it resulted in the highest frequency of this fragmentation. Both Gly
and Pro led to very small abundances of this fragment. It was theorized that Val, Ile,
and Leu led to enhanced N-terminal cleavage to due conformational effects, locking the
peptide into a reactive conformation. This would also explain the relative non-reactivity
of the Gly residue, allowing the peptide to move freely.12
The fragmentation of deprotonated peptides containing proline has also been ex-
amined. Interestingly, the proline effect was still present. Harrison’s research suggests
that there are more driving forces than just the high proton affinity of proline and the
strain involved in the formation of the protonated bicyclic oxalone. The presence of the
effect in deprotonated peptides suggests that the stable neutral leaving species created
by breaking the N-terminal bond plays a role in the directed cleavage.20
1.2.3 Lysine Effect
Proline’s effects on directed peptide cleavage are very well studied compared to those
of lysine. This is one of the reasons that lysine was chosen as the amino acid of interest
for this study. Previous projects, both in Dr. Poutsma’s lab and in the scientific com-
munity, have identified lysine as a residue of interest in directed peptide fragmentation.
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Table 1.1 – Proton Affinities: Lysine and its Analogs21
Amino Acid PA ( kJ/mol)
Lysine 1006.5(± 7.5)
Ornithine 1001.1(± 6.6)
Daba 975.8(± 7.4)
Dapa 950.2(± 7.2)
1.2.4 Goals of this Experiment
The goal of this experiment is to examine the fragmentation patterns of seven-amino
acid peptides in regards to the effect of lysine and its analogs (Ornithine, Daba, Dapa).
By varying both the location of the lysine on the seven amino acid peptide and the
length of the sidechain (via variation of analog) perhaps an idea of the fragmentation
methodology can be achieved. Each analog has one less methylene group than the prior
analog (Figure 1.7) and thus provides an opportunity to study analogs with decreasing
proton affinities (Table 1.1) with minimal structural change.21
(a) Lysine (b) Ornithine (c) Daba (d) Dapa
Figure 1.7 – Lysine and Analogs
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1.3 Solid Phase Peptide Synthesis
1.3.1 Historical Background
In 1901, Theodore Curtis synthesized the first protected peptide, the same year that
Emil Fischer, who is credited with coining the word peptide synthesized the first dipep-
tide. The peptide synthesis field expanded greatly throughout the twentieth century,
as better protecting groups for the α-amines of amino acids were discovered and bet-
ter coupling agents were found. The first synthesis of a peptide hormone occured in
1953 when Vincent du Vigneaud successfully created oxytocin. But, it was not until
1959 that Bruce Merrifield began to develop the process of solid phase peptide synthesis
(SPPS) for which he would win a Nobel Prize in 1984.22 Merrifield’s paper in which he
introduces the method, Solid Phase Peptide Synthesis: The Synthesis of a Tetrapeptide
is a proof of concept that illustrated the advantages (mostly in time savings) of using
a solid support to attack amino acids to stepwise.23 Soon Merrifields process was auto-
mated and coupled with advances in coupling agents and protecting groups, the era of
on-demand long-numbered peptide synthesis began.22
The synthesis of peptides through SPPS proceeds in a stepwise fashion (the tem-
plate worksheet used in this experiment has been included in the appendix). While
advancements have been made in the field of peptide synthesis, the same general prin-
ciples have remained constant. A protected amino acid is anchored to a resin, it is
deprotected, coupled with another protected amino acid, and so forth. At the end of
the process, the completed peptide is washed with a solution that both deprotects the
final amino acid and cleaves the peptide from the resin. A large advantage of the use of
polystyrene beads is that between each step the growing peptide can be rapidly rinsed
and filtered such that the impurities are washed away and that there is no need to purify
the intermediate peptides.3
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1.3.2 Solid Phase Peptide Synthesis Procedural Overview
The first step in the synthesis of a peptide (via SPPS) is the attachment of the C-
terminal amino acid to a resin bead. It is possible to purchase protected amino acids al-
ready attached to polyethylene resin beads. In this experiment Wang resins were used (4-
hydroxymethylphenoxy10). The amino acids used were all Fluorenylmethyloxycarbonyl-
protected (Fmoc-protected) amino acids. The Fmoc group can be easily added to pro-
tect an amine through reaction with Fmoc-Cl24 or Fmoc-ONSu,22 but again, for this
experiment the amino acids were purchased with an Fmoc protecting group already
present. In the first step, the Fmoc protecting group of the C-terminal residue is re-
moved with a 20/80 solution of Piperidine/Dimethylformamide (DMF). In this case, a
deprotection step of twenty-five minutes was used with a change of the Piperidine/DMF
solution five minutes into the twenty-five minute step. Now the deprotected residue is
ready to react with the next amino acid.
After thoroughly rinsing the now deprotected C-terminal residue with stepwise
rinses of DMF and dichloromethane (DCM), the second (or second to last if read-
ing from N-terminal to C-terminal) protected amino acid can be added to create a
peptide bond with the first residue. This is facilitated through the use of a cou-
pling agent, in this case 1H-Benzotriazolium 1-[bis(dimethyl-amino)methylene]-5-chloro-
hexafluorophosphate (1-),3-oxide or HCTU with an amount of DIEA. Addition of each
amino acid usually takes anywhere from 20 to 120 minutes depending on the method
and reactants used, though recently a group showed a proof of concept demonstrating
the addition of an amino acid every five minutes.25 The time limiting factor in the syn-
thesis of a peptide is the agent used to facilitate the coupling.26 This experiment was
done with a coupling time of forty-five minutes per residue. After rinsing, the growing
peptide could be deprotected once again and another amino acid could be added.
Once the desired sequence has been achieved, it is necessary to cleave the peptide
from the resin bead and deprotect any side chains that were protected (lysine and its
analogs must have their amine groups protected to prevent any side reactions). Added
to the reaction vessel is a cleavage solution consisting of 95% trifluoroacetic acid (TFA),
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2.5% deionized water, and 2.5% triisopropyl silane. The TFA acts to cleave the bond
to the resin as well as to other protecting groups on the lysine and lysine analogs. The
water and triisopropyl silane molecules are meant to act as scavengers and prevent the
reactive cations produced from the TFA processes from reacting with the peptide.
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Chapter 2
Methods
2.1 Materials
All protected amino acids as well as the amino acids attached to Wang resins were
acquired from commercial sources. The list of modified amino acids used and their
respective sources is in Table 2.1.
The dichloromethane (DCM) and dimethylformamide (DMF) as well as piperidine
and ethyl ether were purchased from Fischer Scientific. The coupling agent HCTU was
also purchased from Novabiochem in la Jolla, California. The N, N-diisopropylethylamine
(DIEA), trifluoroacetic acid (TFA), and triisopropyl silane were acquired from Sigma
Aldrich.
The synthesis glassware setup (Figure 2.1) consisted of a Kontes 50 mL cylindrical
peptide synthesis vessel. The vessel has a fritted disc that allows washes of reagents
while preventing the loss of the resin beads and the peptides attached to the resin. A
gas inlet fed into a three way joint that allowed flow in only two directions at a time.
This allowed argon gas to be bubbled through the mixture as well as the ability to
vacuum the liquid into a waste container which was attached to the house vacuum.
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Table 2.1 – Amino Acid Materials
Wang Resins
Resin Manufacturer
Fmoc-Ala-Wang ChemPep Inc. (Miami, FL)
Fmoc-Lys(Boc)-Wang ChemPep Inc. (Miami, FL)
Fmoc-Daba(Boc)-Wang ChemPep Inc. (Miami, FL)
Fmoc-Dapa(Boc)-Wang ChemPep Inc. (Miami, FL)
Fmoc-Orn(Boc)-Wang ChemPep Inc. (Miami, FL)
Protected Residues
Amino Acid Manufacturer
Fmoc-Ala ChemPep Inc. (Miami, FL)
Fmoc-Lys(Boc) Novabiochem (la Jolla, CA)
Fmoc-Daba(Boc) Novabiochem (la Jolla, CA)
Fmoc-Dapa(Boc) ChemPep Inc. (Miami, FL)
Fmoc-Orn(Boc) ChemPep Inc. (Miami, FL)
Figure 2.1 – Synthesis Vessel Setup10
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2.2 Peptide Synthesis in Detail: An Example Synthesis of
Ala-Lys
Since peptides are synthesized from the C-terminus to the N-terminus in the SPPS
method for Ala-Lys the first thing needed is the Fmoc-Lys(Boc)-Wang resin. This is
a protected lysine residue (on both amines (the Boc protecting group stays until the
end, whereas the Fmoc protecting group gets washed away prior to the next coupling)
that will need to be weighed and carefully placed into the peptide synthesis vessel with
a 50/50 mix of DCM/DMF. This mixture should be agitated gently via an inert gas
(argon was used in this experiment) for thirty minutes to swell the resin beads. After
the swelling is complete, the mixture is suctioned into the waste container and a small
amount of DMF is used to rinse the beads.
Next, the beads are mixed with a 20/80 solution of piperidine/DMF for five min-
utes followed by a twenty minute agitation period. The piperidine acts to remove the
Fmoc protecting group without disturbing the Boc protecting group on the lysines
side chain. The piperidine scavenges the liberated dibenzoulvene to create a fulvene-
piperidine adduct.22 Once this step is complete, the beads are rinsed twice with DMF
for one minute each followed by four one minute rinsings of DCM.
The beads are now prepared to be coupled with Fmoc-Ala. An excess amount of
Fmoc-protected alanine, based on the loading capacity of the resin (this calculation has
been automated via the creation of an Excel spreadsheet which is available online), is
added to the vessel in addition to DMF, an appropriate amount of HCTU, as well as
DIEA for the coupling step. A good deal of the summer of 2009 was spent perfecting
the coupling step. After dozens of test peptides made with various coupling times, 45
minutes was settled upon as the coupling length with the best results before hitting
dimishing returns. For peptides with seven amino acids the first few coupling reactions
are the most important as without success there, the subsequent residues can not be
added. Because of this, special care was taken to ensure that at least 45 minute coupling
times were used for every step of every synthesis of the seven amino acid peptides.
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After the 45 minute coupling reaction, the solution was suctioned into the waste con-
tainer and then the beads are rinsed again with two washes of DMF and four washes of
DCM (as before). At this point the dipeptide needs to be cleaved from the resin and the
protecting Boc and Fmoc groups need to be removed. To do this, first the peptide was
rinsed with the 20/80 solution of piperidine/DMF once again (again with two washes: 5
minutes followed by a 20 minute wash). This removes the Fmoc group on the N-terminus
of the dipeptide. The flourene ring system of the 9-fluorenylmethyloxycarbonyl (Fmoc)
group makes the hydrogen on the β carbon acidic and is therefore susceptible to removal
by weak bases such as piperidine, a secondary amine.22 The Boc protecting group on
the lysine will be removed at the same time as the cleavage from the resin. Before this
can take place, however, the beads must be rinsed again with two, one minute, washes
of DMF, followed by four, one minute, washes of DCM. The beads at this point must
be completely vacuumed dry before the addition of the cleavage solution. As mentioned
previously, the cleavage solution consists of triisopropyl silane, water, and trifluoroacetic
acid. This solution was added to the vessel and bubbled with special care to the vigor of
the bubbling for ninety minutes. The vessel was covered with parafilm (containing holes
poked in the film) during the cleaving step due to the high volatility of the cleavage
solution. Some peptides, curiously, would be different colors during this phase.
The final steps consisted of extraction of the peptide from the cleavage solution
which were suctioned into a clean 100 mL round bottom flask and stored in the freezer
overnight after addition of 30 mL of cold anhydrous ethyl ether. This allows the peptide
to come out of solution and facilitates easy removal via centrifugation and decantation.
The final solid product, on the inside of the test tubes following decanting the solution
was dissolved in a mixture of 50/50 methanol/water and stored in the freezer until
analysis via electrospray mass spectrometry was possible. At that point, a new solution
was made for analysis consisting of approximately 1-5% acetic acid with the remainder
being a 1:1 mix of methanol and water. The addition of acetic acid facilitates the
creation of a charged peptide for analysis in the mass spectrometer. Note: the peptide
synthesis methods used in this experiment were extremely similar to those used by
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Matthew Bernier10 which were based upon Chan27 and Hood’s26 methods.
2.3 Fragmentation of Peptides via MS/MS
After the peptides were created they were analyzed using a Finnigan LCQ-DECA ion
trap mass spectrometer (a simple schematic is shown in Figure 2.2). This instrument
uses an ESI source. Injected to the source were solutions containing the peptides in
approximately 48:48:4 solutions of methanol:water:acetic acid. In this way, the peptides
are protonated prior to being injected into the instrument.
Figure 2.2 – ESI Ion Trap Mass Spectrometer10
After going through the heated capillary and being put into the gas phase, the
peptide molecules are sent into focusing octopole elements. These focusing octopoles
optimize the transmission of certain ions into the ion trap and can be tuned for maximum
signal.28 The ions then flow into the ion trap where it is possible to isolate certain
molecules by their mass to charge ratio. Also it is possible to carry out collision-induced
dissociation here, colliding the ions with helium atoms that result in the fragmentation
of the peptide. The fragments are then scanned.
In this study the peptides were injected into the instrument from a 500 µL Gastight
syringe filled with the methanol:water:acetic acid solution. Usually the peptide solution
was injected at a rate of about 900 µL per hour. The heated capillary most often was
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set at 125◦C but was increased occasionally (as high as 200◦C) if it would yield cleaner
spectra.
The most important part to this study was MS/MS where the parent ion (the
entire peptide) could be isolated and then fragmented itself. An isolation width of 5 au
was used initially in each case and adjusted accordingly to get the best isolation with
the most number of ions. After successful isolation, the ion was activated at various
% collision energies using CID. The goal was to get spectra where there were many
fragments visible yet the parent ion had not disappeared. This was possible with most
peptides studied. After CID, spectra were recorded electronically.
2.4 pepFrag and Spectra Analysis
One of the first problems encountered in the analysis of the peptide fragmentation
spectra was the identification of the peaks. Calculating each peak by hand is tedious and
unnecessary. Because of this time sink, a simple Java application was created entitled
pepFrag (and later guiPepFrag) that would take a peptide amino acid sequence and
automatically determine the protonated mass/charge for each of the y-,b-, b-H2O, and
a-type ion fragments. Five hundred lines of code and several dozen hours later there
existed a rather robust version that can quickly calculate fragment peaks (as well as
fragment peaks for cycles) of very large peptides remarkably fast. While this study
only examines peptides of seven amino acids, the ability to look at peptides of several
hundred amino acids is certainly useful. This is by no means a novel concept, but by
writing this software in-house, it was possible to add certain features that facilitated
easy fragment identification. Figure 2.3 shows the evolution of the program (the backend
source code is contained in the appendix) and Figure 2.4 shows sample output for the
peptide Ala-Ala-Ala-Lys-Ala-Ala-Ala.
Not only was guiPepFrag able to be used to streamline much of the peptide iden-
tification process in this experiment, but it was used to help other students in Dr.
Poutsma’s laboratory. The source code will be posted online (as well as made available
in the appendix of this thesis) to be useful to future students.
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Figure 2.3 – The Evolution of pepFrag
Figure 2.4 – Sample guiPepFrag Output: AAAKAAA
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Chapter 3
Results
3.1 Alanine-X-Alanine-Alanine-Alanine-Alanine-Alanine
3.1.1 X = Lysine (Figure 3.1)
As seen in Figure 3.1, the major peak is the b6 ion in the CID spectra for Alanine-
Lysine-Alanine-Alanine-Alanine-Alanine-Alanine. This is the case at both 50% CID
and the higher energy 100% CID (98% and 90% relative abundance respectively). Also,
in both cases the b5 ion is a close second in abundance (55% and 75% relative abundance
respectively). The parent ion is not shown with much abundance in these spectra (it
would be at 573). The peak at 284 m/z is present in all four of the A-X-AAAAA
homolog peptides but has not been identified with any certainty. Also to note is the
abundance of b-type ions and relative lack of y-type ions with the exception of the y5
ion.
3.1.2 X = Ornithine (Figure 3.2)
Interestingly, unlike the A-Lys-AAAAA spectra (Figure 3.1), the major fragment in
the A-Orn-AAAAA spectra (Figure 3.2) is the y5 type ion (instead of the b6). As the
collision energy is increased from 30% to 50% the b6 ion does increase in size dramatically
relative to the y5 but remains subdominant. Also of interest are the significant presences
of the a6 ion as well as the y3 ion which are not present in any of the other A-X-AAAAA
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Figure 3.1 – A-Lys-AAAAA at 50% CID (above) and 100% CID (below)
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Figure 3.2 – A-Orn-AAAAA at 30% CID (above) and 50% CID (below)
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spectra.
3.1.3 X = Daba (Figure 3.3)
Again, like the case of A-Orn-AAAAA, A-Daba-AAAAA (Figure 3.3) has a dominant
y5 fragment. The next largest peak is at 456 mz and is the b6 fragment. This spectra
has considerably fewer fragments than the two spectra of longer side chain lengths.
This is presumably due to the shortening side chain giving the peptide fewer regions to
fragment. The mystery peak around 285 m/z is also present in these spectra though it
only becomes significant when the collision energy is raised to 60% from 50%.
3.1.4 X = Dapa (Figure 3.4)
Just when there seemed to be a trend of large abundances of y5 ion fragments in the
A-Orn-AAAAA and A-Daba-AAAAA spectra (Figures 3.2 and 3.3), A-Dapa-AAAAA
(Figure 3.4) does not have a significant peak for a y5 ion but rather exhibits a large b6
ion fragment, much like the A-Lys-AAAAA spectra. The trend of spectra ”cleaning”
continues as fewer fragments are present with shorter side chains on the lysine analog.
Also to note are the large relative presences of the b7 ion (almost as much as the b6 at
both collision energies) and the large presence of the b5 ion. No significant presence of
any y-type ion was detected.
3.2 Alanine-Alanine-X-Alanine-Alanine-Alanine-Alanine
3.2.1 X = Lysine (Figure 3.5)
The dominant peak in the spectra of AA-Lys-AAAA (Figure 3.5) is the b6 ion at 484.
The b5 and b4 fragments are the next highest in abundance with y5 being the fourth
most abundant fragment. The spectra are relatively identical even when the collision
energy was increased from 50% to 100%.
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Figure 3.3 – A-Daba-AAAAA at 50% CID (above) and 60% CID (below)
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Figure 3.4 – A-Dapa-AAAAA at 50% CID (above) and 60% CID (below)
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Figure 3.5 – AA-Lys-AAAA at 50% CID (above) and 100% CID (below)
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Figure 3.6 – AA-Orn-AAAA at 50% CID (above) and 55% CID (below)
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3.2.2 X = Ornithine (Figure 3.6)
Unlike the A-X-AAAAA series, none of the spectra in the AA-X-AAAA series have
dominant y-type ions. The AA-Orn-AAAA is no exception (Figure 3.6). The two
largest peaks at both collision energies are the b6 and b3 ions. Interestingly, the b3
ion was barely detected in the AA-Lys-AAAAA spectra. This is certainly unique and
happens to be the largest peak at 50% CID. The only y-type ions detected were the
y4 ion which was the sixth most abundant species at 50% CID and the fourth most
abundant at 55% CID and the y5 which was barely present.
3.2.3 X = Daba (Figure 3.7)
In the AA-Daba-AAAA spectra (Figure 3.7) there are many similarities to the AA-
Orn-AAAA spectra (Figure 3.6). Again there are many b-type fragments as well as
detectable amounts of the y4 and y5 ions. Also, just like the ornithine spectra, at
lower collision energies the b3 fragment is dominant and at higher energies the b6 ion is
dominant. The largest difference between the two spectra is that there is an enhanced
presence of the b7 ion in the peptide containing daba.
3.2.4 X = Dapa (Figure 3.8)
The AA-Dapa-AAAA specta (Figure 3.8) is most interesting because again, with the
shorter side chain, there are fewer fragments. The three most dominant fragments are
the b5, b6, and b7 fragment ions, but there are small amounts of the y4 and y5 ions as
well. The b6 ion is dominant at both 50% and 55% CID. The dominance of the b6 ion
is a trend that is shown in all four versions of the AA-X-AAAA peptide.
3.3 Alanine-Alanine-Alanine-X-Alanine-Alanine-Alanine
3.3.1 X = Lysine (Figure 3.9)
In the spectra of AAA-Lys-AAA (Figure 3.9) the dominant fragment is at 484 mz and
is the b6 ion. The b5 and b4 ions come in close at second and third in terms of relative
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Figure 3.7 – AA-Daba-AAAA at 50% CID (above) and 55% CID (below)
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Figure 3.8 – AA-Dapa-AAAA at 50% CID (above) and 55% CID (below)
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Figure 3.9 – AAA-Lys-AAA at 35% CID (above) and 75% CID (below)
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abundance at both 35% and 75% CID. The only y-type fragment was the y4 present at
350 mz. Interestingly, there is a substantial amount of the a6 ion which was also seen
in A-Orn-AAAAA.
3.3.2 X = Ornithine (Figure 3.10)
AAA-Orn-AAA (Figure 3.10) fragments similarly to AAA-Lys-AAA (Figure 3.9). The
one significant difference between these spectra, however, is that the b4 ion fragment in
AAA-Orn-AAA is dominant over the b6 by a large margin of relative abundance. Two
y-type ions are present, though barely. Also present in small quantities is the a6 ion
which was also observed in the spectra of AAA-Lys-AAA.
3.3.3 X = Daba (Figure 3.11)
The AAA-Daba-AAA (Figure 3.11) spectra closely resembles the AAA-Orn-AAA spec-
tra. The b4 ion fragment is again the dominant fragment and similarly it take a higher
collision energy to allow the b6 ion to be formed, not appearing until a CID of 50%.
Small amounts of the y4 and y5 ions are present, but like the other spectra discussed,
b-type ions far outnumber the y-types.
3.3.4 X = Dapa (Figure 3.12)
AAA-Dapa-AAA fragments (Figure 3.12) in a similar way to the other peptides con-
taining Dapa yielding a spectra devoid of many fragments. The most abundant ion
fragment is the b6 ion that appears at 442 m/z. Also present is the b5 at 371 m/z , the
b7 at 513 m/z and the y5 although in much less quantity.
3.4 Alanine-Alanine-Alanine-Alanine-Alanine-X-Alanine
3.4.1 X = Lysine (Figure 3.13)
This certainly is not the cleanest spectra taken in the experiment (Figure 3.13). Mul-
tiple attempts were taken to get cleaner spectra without success. For some reason the
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Figure 3.10 – AAA-Orn-AAA at 45% CID (above) and 75% CID (below)
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Figure 3.11 – AAA-Daba-AAA at 45% CID (above) and 50% CID (below)
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Figure 3.12 – AAA-Dapa-AAA at 50% CID (above) and 57% CID (below)
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Figure 3.13 – AAAAA-Lys-A at 25% CID (above) and 75% CID (below)
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peptides with the non-Alanine residue on their sixth position proved to be uniquely
difficult to synthesize and isolate effectively. AAAAA-Lys-A fragments in such a way
that many of the lower mass fragments are visible. The b4 ion is particularly evident at
the lower CID energy. An unknown peak at 311 m/z then becomes the dominant peak
at the higher energy level of 75%.
3.4.2 X = Daba (Figure 3.14)
Notice that the AAAAA-Orn-A spectra was not included. This is because of difficulty
in the synthesis which was done three times, each unsuccessful. Figure 3.14 shows the
AAAAA-Daba-A spectra which is dominated by the b6 ion at 456 m/z and the b5 ion
at 356 m/z. The y4 ion is visible, but barely, as is the y5 ion. The third most abundant
ion in both spectra is the b7 which grows in relative abundance as the collision energy
increases from 60% to 75%.
3.4.3 X = Dapa (Figure 3.15)
This spectra (Figure 3.15) is cleaner than the AAAAA-Lys-A spectra (as expected due
to the short length of the Dapa side chain). The three dominant peaks show up at 513,
442, and 356 m/z. These are the b7, b6, and b5 ion fragments respectively. The y4 ion
is present, but barely visible above the baseline noise as is the b3 ion.
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Figure 3.14 – AAAAA-Daba-A at 60% CID (above) and 75% CID (below)
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Figure 3.15 – AAAAA-Dapa-A at 45% CID (above) and 50% CID (below)
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Chapter 4
Discussion
For the purpose of this discussion the residues will be called by their number. The
residue on the N-terminal side is residue #1 and the residue on the C-terminal side is
residue #7.
4.1 Variation of Residue #2
As seen in Figure 4.1, the first position chosen to vary was the second location. This
decision was based on prior research by Matthew Bernier who saw interesting results
varying the same position in pentapeptides. He found the most dominant peak to be
the b4 fragment when X = lysine (two residues away from the lysine). With ornithine in
the same position he found only the b3 fragment ion. The hypothesis was that since the
proton affinities of the two residues are so similar, the difference is the shorter length
of the ornithine residue prevents it from reaching far enough to create the b4 fragment
ion.10
Figure 4.1 – Varying the Second Residue on AXAAAAA
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Figure 4.2 – Example of a y-type Ion
In this study, however, it appears that the length of the residue does not affect
attack down the peptide. Perhaps this is most evident by the dominant fragment in
both 2=Lys and 2=Dapa (the longest and the shortest residues) is the b6 fragment.
This is four residues away from the location of the varied side chain.
Ornithine and daba at this position produce dominant y5 ions which is interesting
because it shows cleavage of the peptide bond on the carbonyl side of position two.
As the energy is ramped up, however, both begin to show the b6 ion fragment that is
dominant with the other two residues.
One conclusion to draw from the differences between these results and Bernier’s is
that perhaps not only the ”floppiness” of the side chain has to be taken into account,
but also the ”floppiness” of the peptide itself. As the peptide gets longer, there are more
bonds that are able to rotate. A bond that looks to be four residues away when linear
(as in Figure 4.1) may be much closer to the side chain in practice. The peptide can
rotate around the bonds involving the α carbon (the carbonyl carbon & nitrogen bond
has partial double bond characteristics) so each amino acid added to a peptide greatly
increases the number of possible three-dimension conformations to the point that the
length of the side chain of the second residue may not matter.
4.2 Variation of Residue #3
The case of the variation of the residue in the third position is interesting. Most of
the fragments are still b-type ions and again, it is hard to rationalize an effect of the
length of the residue on the ion fragments created. The lysine version creates b6, b5,
and b4 fragments (each with diminishing abundances) whereas the much shorter Dapa
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iteration creates b7, b6, and b5 with ease.
There is a pattern, however, developing when comparing the variation of residue #2
with that of residue #3. The two intermediate length residues (ornithine and daba)
show similar spectra with almost equivalent peaks for the b3 and b6 fragment ions. The
presence of the b3 ion is unique to these two variations among the residue #3 peptides.
To create the b3 fragment, the peptide bond immediately to the C-terminal side of the
residue of interest must break. Perhaps the intermediate length of these side chains
makes it possible to affect fragmentation at peptide bonds closer to position 3. As one
begins to examine fragments further away from the varied residue it is possible that the
effects of peptide ”floppiness” begin to overcome the differences in residue side chain
length. The presence of the y5 ion in the ornithine and daba versions of the peptides
varied at residue #2 helps to confirm this hypothesis.
4.3 Variation of Residue #4
Variation of residue #4 gives the opportunity to look at a symmetric peptide with
two cleavage sites on either side of the residue of interest. The interesting thing about
these spectra is that they are remarkably similar to those resulting from the variation
of residue #3.
The spectra for the lysine- and dapa-containing peptides are very similar with the
same major peaks present. The two middle-length residues again exhibited similar
cleavage patterns, again showing a b-fragment ion immediately to the C-terminal side
of the residue (b4) as well as the b6 that was also present with these peptides containing
these residues on the third position.
4.4 Variation of Residue #6
It is hard to get too much information out of this part of the experiment. The lysine
spectra is incredibly messy and besides large presences of b-type ions, there is nothing
particularly remarkable. For the first time there are b-type fragments to the N-terminal
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Figure 4.3 – Example of a b-type Ion
side of the residue that are present in large abundances. The b6 fragment is present in
all three versions of this peptide and happens to be the fragment directly next to the
residue of interest on the C-terminal side.
Synthesizing these last peptides proved to be very challenging (hence the poor spec-
tra for the lysine version and the loss of an ornithine version). This is probably due to
the position of the varied residue. When the residue is added early in the synthesis there
is considerably more room for error.With each step yield goes down. The lysine analog
residues have proven to be occasionally difficult to synthesize into peptides and having
the residues near the carbonyl end does not help. If one of the most difficult synthesis
steps is near the beginning of the synthesis (peptides are synthesized from C-terminal
to N-terminal) then if it doesn’t go as well as it could, all subsequent linkages are more
challenging.
4.5 Future Directions
Due to the interesting effect of peptide length in conjunction with residue side chain
length, it would be interesting to do studies on peptides even longer than seven residues
and see if the trend continues. This may prove to be time prohibitive using manual
SPPS. Automated methods in this case would greatly improve efficiency and yield.
Also, studies on peptides with three and four residues could be interesting as there
might be a transition between the point of residue side chain length importance and
peptide length importance in fragmentation patterns.
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5.1 Synthesis Checklist
Figure 5.1 – Checklist for Peptide Synthesis
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5.2 guiPepFrag Code
1 import java.awt.event .*;
2 import javax.swing .*;
3 import java.text.DecimalFormat;
4 import java.io.*;
5
6 public class mathEngineB implements ActionListener{
7 private JTextField sequence;
8 private static JLabel peptideMass;
9 boolean calcOutput;
10 boolean calcUnique;
11 boolean calcCycles;
12 private JTextField toleranceTextField;
13
14 mathEngineB(JTextField sequenceIn , JLabel pepMass , JCheckBox
calcYesNo , JCheckBox markToleranceYesNo , JTextField
toleranceAllowed , JCheckBox genCyclicYesNo){
15 sequence = sequenceIn;
16 peptideMass = pepMass;
17 toleranceTextField = toleranceAllowed;
18
19 calcYesNo.addItemListener(new ItemListener () {
20 public void itemStateChanged(ItemEvent e) {
21 JCheckBox jCheckBox = (JCheckBox)e.getSource ();
22 if(jCheckBox.isSelected ())
23 calcOutput=true;
24 else
25 calcOutput=false;
26 }
27 });
28
29 markToleranceYesNo.addItemListener(new ItemListener () {
30 public void itemStateChanged(ItemEvent e) {
31 JCheckBox jCheckBox = (JCheckBox)e.getSource ();
32 if(jCheckBox.isSelected ())
50
33 calcUnique=true;
34 else
35 calcUnique=false;
36 }
37 });
38
39 genCyclicYesNo.addItemListener(new ItemListener () {
40 public void itemStateChanged(ItemEvent e) {
41 JCheckBox jCheckBox = (JCheckBox)e.getSource ();
42 if(jCheckBox.isSelected ())
43 calcCycles=true;
44 else
45 calcCycles=false;
46 }
47 });
48 }
49
50 public void actionPerformed(ActionEvent e){
51 String peptideIn = sequence.getText ().trim(); // convert sequence
to a string
52 int peptideLength = peptideIn.length (); // peptide length (
number of amino acids)
53 char peptide [] = peptideIn.toCharArray (); // character array of
peptide , each amino acid in its own cell
54 double readInTol = Double.parseDouble(toleranceTextField.getText ()
.trim());
55 getTotalMass(peptide);
56
57 System.out.println ("read tolerance: " + readInTol);
58
59 if(calcOutput){
60 double regularIonMasses [][] = new double [4][ peptideLength ]; //
creates 2d array for results
61 regularIonMasses = calculateIt(peptideLength , peptide); //
calculates non -cyclic results
62
51
63 printOut(regularIonMasses , peptideLength , peptideIn , calcUnique ,
readInTol); // prints out results
64 }
65
66 if(calcCycles){
67 // Begin Cyclic Calculations (only if Peptide is > 2 aa long)
68 // creates cycles
69 if(peptideLength > 2){
70 char cycles [][] = new char[peptideLength ][ peptideLength -1];
71 int startIndex = 0;
72
73 for(int i = 0; i<peptideLength -1; i++){
74 startIndex = i;
75 for(int j = 0; j<peptideLength; j++){
76 cycles[j][i] = getNext(peptide ,startIndex ,peptideLength);
77 startIndex ++;
78 }
79 }
80
81 //Now we have to run the same calculations as before on the new
peptides
82 double cyclicIonMasses [][][] = new double [4][ peptideLength ][
peptideLength -1];
83
84 char toSend [] = new char[peptideLength ];
85 double toSave [][] = new double [4][ peptideLength ];
86
87 for(int i = 0; i<peptideLength -1; i++){
88 // convert 1st peptide to 1d array
89 for(int j = 0; j<peptideLength; j++){
90 toSend[j]= cycles[j][i];
91 }
92
93 //send to calculator
94 toSave = calculateIt(peptideLength , toSend);
95
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96 // append results to cylic Ion Masses
97 for(int k = 0; k<4; k++){
98 for(int h = 0; h<peptideLength; h++){
99 cyclicIonMasses[k][h][i]= toSave[k][h];
100 }
101 }
102 }
103
104 printOutCycle(cyclicIonMasses , cycles , peptideLength ,
peptideIn); // create file with output results
105 }//end if (generate output files)
106
107 }//end if (cycles)
108 }//end action listener
109
110 public static double [][] calculateIt(int peptideLength , char[]
peptide){
111 double regularIonMasses [][] = new double [4][ peptideLength ];
112
113 // calculate b type ions (length - 1 number of ions)
114 double massToSave = 0;
115
116 for(int i = 0; i<peptideLength; i++){
117
118 int j = 0;
119 if(i>0)
120 j=1;
121 if(i == peptideLength -1){
122 j=2;
123 massToSave = massToSave -17;
124 }
125 massToSave = massToSave + getMassBType(peptide[i], j);
126 regularIonMasses [0][i] = massToSave;
127 // System.out.println(massToSave);
128 }
129
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130 // populate y type ions
131
132 regularIonMasses [1][0]= getTotalMass(peptide)+1;
133 for(int i = 0; i<peptideLength -1; i++){
134 regularIonMasses [1][i+1] = (( getTotalMass(peptide) -
regularIonMasses [0][i] + 2));
135 // System.out.println ("y: " + regularIonMasses [1][i]);
136 }
137
138 //b type minus water
139 for(int i = 0; i<peptideLength; i++){
140 regularIonMasses [2][i]= regularIonMasses [0][i]-18;
141 // System.out.println ("b-h20: " + regularIonMasses [2][i]);
142 }
143
144 //a type ions
145 for(int i = 0; i<peptideLength; i++){
146 regularIonMasses [3][i]= regularIonMasses [0][i]-28;
147 }
148
149 return regularIonMasses;
150 }
151
152 public static boolean [][] isUnique(double [][] results , int
peptideLength , double tolerance){
153 boolean isLocationUnique [][] = new boolean [4][ peptideLength ];
154 double difference = 0.0;
155
156 // initialize with trues
157 for(int i=0; i<peptideLength; i++){
158 for(int j=0; j<4; j++){
159 isLocationUnique[j][i]=true;
160 }
161 }
162
163 // check for falses
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164 for(int k=0; k<peptideLength; k++){
165 for(int l=0; l<4; l++){
166
167
168 for(int j=0; j<4; j++){
169 for(int i=0; i<peptideLength; i++){
170
171 if(!(l==j&&k==i)&&( isLocationUnique[j][i]== true)){
172 difference = Math.abs(results[l][k]-results[j][i]);
173 // System.out.println ("diff " + difference);
174 if(difference <tolerance){
175 isLocationUnique[j][i]= false;
176 isLocationUnique[l][k]= false;
177 }
178 }
179
180 }
181 }
182 }
183 }
184
185 return isLocationUnique;
186
187 }
188
189 public static void printOut(double [][] results , int peptideLength ,
String fileName , boolean calcUnique , double readInTol){
190 try {
191 BufferedWriter out = new BufferedWriter(new FileWriter(
fileName + ".txt"));
192 out.write("For the peptide: " + fileName + "\n");
193 out.write("b type \t y type \t b-H2O \t a type \n");
194
195 if(calcUnique){
196 out.write ("* unique tolerance: " + readInTol + "* (unique)\n
");
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197 out.write("--------------------------------------- \n");
198 boolean uniqueResults [][]= new boolean [4][ peptideLength ];
199 uniqueResults = isUnique(results ,peptideLength ,readInTol);
200
201 for(int i=0; i<peptideLength; i++){
202 for(int j = 0; j<4; j++){
203 if(uniqueResults[j][i]== true){
204 out.write ("(" + roundTwoDecimals(results[j][i]) + ")"
+ "\t \t");
205 }
206 else{
207 out.write(roundTwoDecimals(results[j][i]) + "\t \t");
208 }
209 }
210 out.write ("\n");
211 }
212 }
213 else{
214 out.write("--------------------------------------- \n");
215 for(int i=0; i<peptideLength; i++){
216 for(int j = 0; j<4; j++){
217 out.write(roundTwoDecimals(results[j][i]) + "\t \t")
;
218 }
219 out.write ("\n");
220 }
221 }
222
223 out.close();
224 System.out.println ("[ output file sucessfully created ]");
225
226 } catch (IOException e) {
227 }
228 }// end printOut ()
229
230
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231 public static void printOutCycle(double [][][] results , char [][]
cycles ,int peptideLength , String fileName){
232 try {
233 BufferedWriter out = new BufferedWriter(new FileWriter ("
cylic_" + fileName + ".txt"));
234
235 out.write("For the peptide: " + fileName + "\n");
236 out.write("b type \t y type \t b-H2O \t a type \n");
237 out.write("--------------------------------------- \n");
238
239
240 for(int h = 0; h<peptideLength -1; h++){
241 out.write(" Cycle considered: ");
242 for(int s=0; s<peptideLength; s++){
243 out.write(cycles[s][h]);
244 }
245 out.write ("\n");
246
247 for(int i=0; i<peptideLength; i++){
248 for(int j = 0; j<4; j++){
249 out.write(roundTwoDecimals(results[j][i][h]) + "\t \
t");
250 }
251 out.write ("\n");
252 }
253 out.write ("\n");
254 }
255
256 out.close();
257 System.out.println ("[ cylic output file sucessfully created
]");
258
259 } catch (IOException e) {
260 System.out.println ("Error" + e);
261 }
262 }// end printOutCycle ()
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263
264 public static String roundTwoDecimals(double d) { // rounds to two
decimals for nice presentation in the output file easy to change
later if one desires a different format
265 DecimalFormat twoDForm = new DecimalFormat ("#.00");
266 return twoDForm.format(d);
267 }
268
269 public static double getMassBType(char aminoAcid , int
isFirstMiddleLast){
270 //if first , the int will be 0, if in the middle the int will be 1,
if last aa , the int will be 2
271 double massToReturn = 0;
272 massToReturn = getAAMass(aminoAcid);
273
274 // correction factors
275 if(isFirstMiddleLast == 0){
276 massToReturn = massToReturn - 17;
277 }
278 if(isFirstMiddleLast == 1){
279 massToReturn = massToReturn - 18;
280 }
281 if(isFirstMiddleLast == 2){
282 massToReturn = massToReturn - 1;
283 }
284
285 return massToReturn;
286 }
287
288 // returns the total mass of the peptide , used to calculate y type
ions from corresponding b types
289 public static double getTotalMass(char[] aminoAcid){
290 double totalMass =0;;
291
292 for(int i =0; i<aminoAcid.length; i++){
293 totalMass = totalMass + getAAMass(aminoAcid[i]);
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294 }
295
296 totalMass = totalMass - (( aminoAcid.length -1) *18.0148);
297
298 // System.out.println ("Total mass: " +totalMass);
299 peptideMass.setText(roundTwoDecimals(totalMass)); // outputs to
JLabel
300 return totalMass;
301 }
302
303 // returns the next character in the array , regardless of location
304 //this is for the wraparound case in the cyclic computations
305 // updated in mathEngineB
306 public static char getNext(char aminoAcid [], int location , int
length){
307 int scaledIndex = location % length;
308 if(scaledIndex ==length -1){
309 return aminoAcid [0];
310 }
311 return aminoAcid[scaledIndex +1];
312 }
313
314 public static double getAAMass(char aa){
315 // these are amino acid masses H2N -CHR -COOH
316 double massToReturn = 0;
317 aa = Character.toLowerCase(aa);
318
319 switch (aa) {
320 case ’a’: massToReturn = 89.09; break; // alanine
321 case ’k’: massToReturn = 146.19; break; // lysine
322 case ’r’: massToReturn = 174.2; break; // arginine
323 case ’n’: massToReturn = 132.12; break; // asparagine
324 case ’d’: massToReturn = 133.1; break; // aspartic acid
325 case ’c’: massToReturn = 121.16; break; // cysteine
326 case ’e’: massToReturn = 147.13; break; // glutamic acid
327 case ’q’: massToReturn = 146.14; break; // glutamine
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328 case ’g’: massToReturn = 75.07; break; // glycine
329 case ’h’: massToReturn = 155.15; break; // histidine
330 case ’i’: massToReturn = 131.17; break; // isoleucine
331 case ’l’: massToReturn = 131.17; break; // leucine
332 case ’m’: massToReturn = 149.21; break; // methionine
333 case ’f’: massToReturn = 165.19; break; // phenylalanine
334 case ’p’: massToReturn = 115.13; break; // proline
335 case ’s’: massToReturn = 105.09; break; // serine
336 case ’t’: massToReturn = 119.12; break; // threonine
337 case ’w’: massToReturn = 146.13; break; // tryptophan
338 case ’y’: massToReturn = 181.19; break; // tyrosine
339 case ’v’: massToReturn = 117.15; break; // valine
340 case ’z’: massToReturn = 104.11; break; //DAPA
341 case ’b’: massToReturn = 118.14; break; //DABA
342 case ’o’: massToReturn = 132.16; break; // Ornithine
343 case ’1’: massToReturn = 101.13; break; //aze
344 case ’2’: massToReturn = 129.13; break; //pip
345 case ’3’: massToReturn = 103.13; break; //nme
346 default: System.out.println (" Invalid Amino Acid .");break;
347 }// end switch
348
349 return massToReturn;
350 }// end getAAMass ()
351 }
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